Screener
Rigel Pharmaceuticals RIGL Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue reserves and refund liability | 364 | 1,495 |
| Other accrued liabilities | (1,792) | (2,954) |
| Lease liabilities | (145) | 1,035 |
| Net cash provided by (used in) operating activities | 2,725 | (893) |
| Investing activities | ||
| Maturities of short-term investments | 15,945 | 11,100 |
| Purchases of short-term investments | (23,920) | (21,652) |
| Net cash used in investing activities | (7,975) | (10,552) |
Item 1. Financial Statements
FAQ
- What is Rigel Pharmaceuticals's operating cash flow?
- Rigel Pharmaceuticals (RIGL) reported operating cash flow of $2.73M in Q1 2026.
- How has Rigel Pharmaceuticals's operating cash flow changed year-over-year?
- Rigel Pharmaceuticals's operating cash flow increased by 405.2% year-over-year, from -$893K to $2.73M.
- What is the long-term trend for Rigel Pharmaceuticals's operating cash flow?
- Over 3 years (2022 to 2025), Rigel Pharmaceuticals's operating cash flow has grown at a 0.9% compound annual growth rate (CAGR), from -$73.76M to $75.66M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Rigel Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude